Incremental Cost

Incremental cost shows how the expected total cost of one healthcare option differs from the cost of its comparator. The sections below explain how the difference is calculated, what cost components contribute to it, and how positive and negative values should be interpreted. They also connect incremental cost to cost-effectiveness analysis and explain why analytical choices can change the result.

The comparison is meaningful only when both alternatives are evaluated for the same population using consistent assumptions, costing methods and analytical boundaries.

What incremental cost compares

Incremental cost compares two defined alternatives rather than describing the cost of one option in isolation. The comparison is meaningful only when both alternatives have been evaluated for the same population and under consistent analytical assumptions.

• The intervention is the healthcare option being evaluated.
• The comparator is the relevant alternative against which the intervention is assessed.
• Both options must use the same perspective, time horizon, currency, price year and discounting rules.
• The comparison should include all cost categories relevant to the chosen perspective.

How incremental cost is calculated

Incremental cost is calculated by subtracting the expected total cost of the comparator from the expected total cost of the intervention. The direction of subtraction must remain explicit because reversing the alternatives changes the sign of the result.

ΔC = C intervention − C comparator

In this calculation:

• ΔC is the incremental cost.
• C intervention is the expected total cost of the intervention.
• C comparator is the expected total cost of the comparator.

If the intervention costs £18,500 per person and the comparator costs £16,000 per person, the incremental cost is £2,500.

ΔC = £18,500 − £16,000 = £2,500

The intervention therefore costs £2,500 more per person than the comparator under the assumptions used in the analysis.

What creates the difference in cost

The difference between the alternatives may arise from several cost components, not just the acquisition price of a medicine or technology. Showing the components separately helps readers understand which changes drive the final incremental cost and whether claimed savings are plausible.

• Treatment acquisition costs may increase or reduce incremental cost.
• Administration, monitoring and diagnostic requirements may differ between the alternatives.
• Adverse events may create additional treatment costs or cost offsets.
• Changes in disease progression may alter later healthcare use.
• Implementation, training or infrastructure costs may be relevant.
• End-of-life, social-care, patient or productivity costs may be included when required by the chosen perspective.

A cost offset reduces the additional cost associated with an intervention, but it should not automatically be described as a cash saving. Whether expenditure can actually be avoided depends on timing, capacity and the budget holder's ability to release resources.

How to interpret the result

The sign of incremental cost indicates whether the intervention is expected to cost more or less than its comparator. It does not, by itself, show whether the intervention provides good value because health outcomes and other consequences must also be considered.

• A positive incremental cost means the intervention is expected to cost more than the comparator.
• A negative incremental cost means the intervention is expected to cost less than the comparator.
• An incremental cost of zero means the alternatives have equal expected costs within the precision of the analysis.
• Incremental cost does not establish cost-effectiveness without corresponding evidence about incremental outcomes.
• A negative incremental cost is not sufficient to establish dominance unless the intervention also produces outcomes at least as good as those of the comparator.

How incremental cost relates to cost-effectiveness analysis

Cost-effectiveness analysis combines incremental cost with the corresponding difference in health outcomes. Incremental cost forms the numerator of the incremental cost-effectiveness ratio and also contributes to incremental net monetary benefit.

ICER = ΔC ÷ ΔE

INMB = (λ × ΔE) − ΔC

In these calculations:

• ΔC is incremental cost.
• ΔE is incremental effectiveness.
• λ is the chosen monetary value placed on one additional unit of health outcome.
• Incremental cost and incremental effectiveness must compare the same alternatives in the same direction.
• The ICER should not be interpreted without examining the signs of both incremental cost and incremental effectiveness.
• Incremental net monetary benefit expresses the joint result on a monetary scale for a stated value of λ.

Why analytical choices can change incremental cost

Incremental cost is an output of the analysis rather than an immutable property of a technology. Its value can change when the perspective, time horizon, comparator, included cost categories, prices, discount rate or modelling assumptions change.

• The analytical perspective determines whose costs are counted.
• The time horizon determines how long costs and cost offsets are followed.
• Discounting changes the present value assigned to future costs.
• The comparator determines the baseline from which the difference is measured.
• The currency and price year affect whether cost estimates are comparable.
• Model structure and assumptions determine how resource use accumulates over time.

Common mistakes and safeguards

Incremental cost can be misleading when alternatives are not evaluated consistently or when the cost difference is reported without sufficient explanation. Transparent component-level reporting allows readers to identify inconsistent assumptions and understand why the result changes.

• Do not subtract costs calculated for different populations or time horizons.
• Do not mix currencies or price years without appropriate conversion and adjustment.
• Do not compare discounted costs for one option with undiscounted costs for another.
• Do not omit relevant downstream costs merely because the intervention price is the initial focus.
• Do not present a modelled cost offset as an immediately realisable budget saving without further evidence.
• Always name the intervention, comparator, perspective, time horizon, currency and price year.

Worked cost-component example

A component-level calculation shows how individual increases and offsets combine into the total incremental cost. This makes the result easier to audit than presenting only the final difference.

• Treatment: The intervention costs £12,000 and the comparator costs £8,000. The incremental treatment cost is £4,000.
• Administration: The intervention costs £1,000 and the comparator costs £1,500. The incremental administration cost is −£500.
• Monitoring: The intervention costs £1,500 and the comparator costs £1,000. The incremental monitoring cost is £500.
• Adverse events: The intervention costs £500 and the comparator costs £1,500. The incremental adverse-event cost is −£1,000.
• Later healthcare use: The intervention costs £3,500 and the comparator costs £4,000. The incremental cost of later healthcare use is −£500.
• Total cost: The intervention costs £18,500 and the comparator costs £16,000. The total incremental cost is £2,500.

The intervention adds £4,500 in treatment and monitoring costs but offsets £2,000 through lower administration, adverse-event and later healthcare costs. Its net incremental cost is therefore £2,500 per person.

Further learning

The following resources explain how costs should be identified, measured, valued and reported in comparative economic evaluation. Final links will point to their exact HealthEconomics.wiki Library records once the permanent Library URL structure is confirmed.

• Methods for the Economic Evaluation of Health Care Programmes, Drummond and colleagues — LIB-000001.
• NICE Health Technology Evaluations: The Manual (PMG36), National Institute for Health and Care Excellence — LIB-000099.
• Guidelines for the Economic Evaluation of Health Technologies: Canada, 4th Edition, CADTH/CDA-AMC — LIB-000117.

A verified “View all resources for Incremental Cost” destination should use the exact concept slug incremental-cost. No URL pattern should be guessed before the website implementation is confirmed.